Literature DB >> 3921382

Plasma oxalate concentration and oxalate distribution volume in patients with normal and decreased renal function.

J A Prenen, E J Dorhout Mees, P Boer.   

Abstract

In twenty-one patients (sixteen male, five female) with various kidney diseases including primary hyperoxaluria type I (four patients), the plasma oxalate level was calculated from the isotopically determined oxalate clearance and the chemically determined urinary oxalate excretion. The apparent oxalate distribution volume was assessed as well. In patients with impaired kidney function (n = 12), the oxalate clearance was lower and the biological half-life and plasma concentration were higher than in patients with normal kidney function (n = 10). No differences were found in the oxalate-to-creatinine clearance ratio (mean value 1.93), urinary oxalate excretion and apparent oxalate distribution volume. A linear relation was found between the oxalate and creatinine clearance, while the clearance ratio was independent of the degree of renal failure. The apparent oxalate distribution volume was 1.45 times the estimated extracellular fluid volume. Because the isotopically determined plasma oxalate levels are lower than chemically measured ones, a quick and better estimation of plasma oxalate can be made from the urinary oxalate excretion and the creatinine clearance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921382     DOI: 10.1111/j.1365-2362.1985.tb00142.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

1.  The trigger-maintenance model of persistent mild to moderate hyperoxaluria induces oxalate accumulation in non-renal tissues.

Authors:  Susan Ruth Marengo; Brian S Zeise; Christopher G Wilson; Gregory T MacLennan; Andrea M P Romani
Journal:  Urolithiasis       Date:  2013-07-03       Impact factor: 3.436

Review 2.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

3.  Partitioning of 14C-oxalate excretion in rats during a persistent oxalate challenge.

Authors:  Susan Ruth Marengo; Ailin Zhang; Edward J Traverso
Journal:  Urol Res       Date:  2008-10-16

4.  Intra-operative continuous renal replacement therapy during combined liver-kidney transplantation in two patients with primary hyperoxaluria type 1.

Authors:  Casper F M Franssen; Ido P Kema; Douglas J Eleveld; Robert J Porte; Jaap J Homan van der Heide
Journal:  NDT Plus       Date:  2011-02-10

5.  Critically ill, tubular injury, delayed early recovery: characteristics of acute kidney disease with renal oxalosis.

Authors:  Jing Zhou; Xiaojuan Yu; Tao Su; Suxia Wang; Li Yang
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

6.  Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal Disease.

Authors:  Theresa Ermer; Christoph Kopp; John R Asplin; Ignacio Granja; Mark A Perazella; Martin Reichel; Thomas D Nolin; Kai-Uwe Eckardt; Peter S Aronson; Fredric O Finkelstein; Felix Knauf
Journal:  Kidney Int Rep       Date:  2017-06-08

7.  Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study.

Authors:  Natalia Stepanova; Victoria Driianska; Lesya Korol; Lyudmyla Snisar; Larysa Lebed
Journal:  Korean J Intern Med       Date:  2021-06-25       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.